Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.

Beletsky L, Grau LE, White E, Bowman S, Heimer R.

Addiction. 2011 Feb;106(2):357-65. doi: 10.1111/j.1360-0443.2010.03149.x. Epub 2010 Nov 4.

2.

Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventions.

Beletsky L, Grau LE, White E, Bowman S, Heimer R.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):145-9. doi: 10.1016/j.drugalcdep.2011.05.034. Epub 2011 Jun 25.

3.

The impact of legalizing syringe exchange programs on arrests among injection drug users in California.

Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH.

J Urban Health. 2007 May;84(3):423-35.

4.

Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH.

Addiction. 2007 Apr;102(4):638-46. Epub 2007 Feb 6.

PMID:
17286637
5.

Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.

Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R; Diffusion of Benefit through Syringe Exchange Study Team..

Addiction. 2004 Sep;99(9):1136-46.

PMID:
15317634
6.

Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective.

Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H.

Int J Drug Policy. 2014 Jan;25(1):105-11. doi: 10.1016/j.drugpo.2013.06.005. Epub 2013 Aug 2.

7.

Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.

Kral AH, Anderson R, Flynn NM, Bluthenthal RN.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1307-12.

PMID:
15385739
8.

Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

Tempalski B, Cooper HL, Friedman SR, Des Jarlais DC, Brady J, Gostnell K.

Int J Drug Policy. 2008 Apr;19 Suppl 1:S47-58. doi: 10.1016/j.drugpo.2007.11.011. Epub 2008 Mar 4.

9.

Syringe confiscation as an HIV risk factor: the public health implications of arbitrary policing in Tijuana and Ciudad Juarez, Mexico.

Beletsky L, Lozada R, Gaines T, Abramovitz D, Staines H, Vera A, Rangel G, Arredondo J, Strathdee SA.

J Urban Health. 2013 Apr;90(2):284-98. doi: 10.1007/s11524-012-9741-3.

10.

Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Rudolph AE, Crawford ND, Ompad DC, Benjamin EO, Stern RJ, Fuller CM.

J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):140-7. doi: 10.1331/JAPhA.2010.09193.

11.

Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.

Bluthenthal RN, Kral AH, Erringer EA, Edlin BR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):505-11.

PMID:
9715848
12.

The association between law enforcement encounters and syringe sharing among IDUs on skid row: a mixed methods analysis.

Wagner KD, Simon-Freeman R, Bluthenthal RN.

AIDS Behav. 2013 Oct;17(8):2637-43. doi: 10.1007/s10461-013-0488-y.

13.

Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.

Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN.

Drug Alcohol Depend. 2006 Feb 1;81(2):167-78. Epub 2005 Jul 25.

PMID:
16043308
14.

Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco.

Bluthenthal RN, Kral AH, Lorvick J, Watters JK.

Med Anthropol. 1997 Dec;18(1):61-83.

PMID:
9458668
15.

Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.

Green TC, Bluthenthal RN, Singer M, Beletsky L, Grau LE, Marshall P, Heimer R.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):74-81. doi: 10.1016/j.drugalcdep.2010.03.022. Epub 2010 May 26.

16.

Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.

Rhodes T, Platt L, Sarang A, Vlasov A, Mikhailova L, Monaghan G.

J Urban Health. 2006 Sep;83(5):911-25.

17.

Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.

Bluthenthal RN, Anderson R, Flynn NM, Kral AH.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):214-22. Epub 2007 Feb 5.

18.

Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.

Zaller ND, Yokell MA, Nayak SM, Fu JJ, Bazazi AR, Rich JD.

J Urban Health. 2012 Aug;89(4):659-70. doi: 10.1007/s11524-012-9669-7.

19.

Legal space for syringe exchange programs in hot spots of injection drug use-related crime.

Allen ST, Ruiz MS, Jones J, Turner MM.

Harm Reduct J. 2016 Apr 26;13:16. doi: 10.1186/s12954-016-0104-3.

20.

Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.

Costenbader EC, Zule WA, Coomes CC.

Int J Drug Policy. 2010 Sep;21(5):425-8. doi: 10.1016/j.drugpo.2009.12.006. Epub 2010 Jan 22.

Supplemental Content

Support Center